Clozapine Tablet, Orally Disintegrating
Product Images NDC 51079-288
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Clozapine (NDC 51079-288). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mylan Institutional Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1: Cumulative Probability Of A Significant Suicide Attempt Or Hospitalization To Prevent Suicide In Patients With Schizophrenia Or Schizoaffective Disorder At High Risk Of Suicidality (Image 02)
Clozapine Orally Disintegrating 100 mg Tablets Unit Carton Label (Image 03)
This is a description of a medication called Clozapine in tablet form. The tablets have a strength of 100mg and some of them contain 7.5mg of phenylketonurics. The tablets are stored in a controlled room at a temperature range of 20-25°C to prevent moisture. The medication is manufactured by Mylan Pharmaceuticals. The packaging contains 40 tablets and the dosage should be determined by a medical professional.*
Image 04
This is a warning label for a drug package from Mylan Inc. The package is not child-resistant and is intended for institutional use only. The instructions advise to keep this and all drugs out of reach of children. The container used for this package is light-resistant. Lot number and expiration date can be found on the package's window.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.